The Patent Finder

Maintenance fees coming due

Aclaris Therapeutics, Inc.

8 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Dec 11, 2026. Unpaid by Jun 11, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 10,316,038Pyrrolopyrimidine Itk Inhibitors for Treating Inflammation and Cancer
In force
Fee due Dec 11, 2026
Lapses if unpaid Jun 11, 2027
 · High confidence
Aclaris Therapeutics, Inc.In forceDec 11, 2026Jun 11, 2027High confidence
US 9,056,110Substituted Pyrimidinone-Phenyl-Pyrimidinyl Compounds
In force
Fee due Dec 16, 2026
Lapses if unpaid Jun 16, 2027
 · High confidence
Aclaris Therapeutics, Inc.In forceDec 16, 2026Jun 16, 2027High confidence
US 9,115,089Methyl/Fluoro-Pyridinyl-Methoxy Substituted Pyridinone-Pyridinyl Compounds and Fluoro-Pyrimidinyl-Methoxy Substituted Pyridinone-Pyridinyl Compounds
In force
Fee due Feb 25, 2027
Lapses if unpaid Aug 25, 2027
 · High confidence
Aclaris Therapeutics, Inc.In forceFeb 25, 2027Aug 25, 2027High confidence
US 11,739,086Substituted Pyrrolopyridine Jak Inhibitors and Methods of Making and Using the Same
In force
Fee due Feb 28, 2027
Lapses if unpaid Aug 30, 2027
 · High confidence
Aclaris Therapeutics, Inc.In forceFeb 28, 2027Aug 30, 2027High confidence
US 11,767,309Methods of Synthesizing Substituted Pyridinone-Pyridinyl Compounds
In force
Fee due Mar 26, 2027
Lapses if unpaid Sep 27, 2027
 · High confidence
Aclaris Therapeutics, Inc.In forceMar 26, 2027Sep 27, 2027High confidence
US 9,145,393Arylpyridinone Itk Inhibitors for Treating Inflammation and Cancer
In force
Fee due Mar 29, 2027
Lapses if unpaid Sep 29, 2027
 · High confidence
Aclaris Therapeutics, Inc.In forceMar 29, 2027Sep 29, 2027High confidence
US 11,820,775Pyrrolopyrimidine Itk Inhibitors
In force
Fee due May 21, 2027
Lapses if unpaid Nov 22, 2027
 · High confidence
Aclaris Therapeutics, Inc.In forceMay 21, 2027Nov 22, 2027High confidence
US 11,844,801Oral Compositions of MK2 Pathway Inhibitor for Treatment of Immune Conditions
In force
Fee due Jun 19, 2027
Lapses if unpaid Dec 20, 2027
 · High confidence
Aclaris Therapeutics, Inc.In forceJun 19, 2027Dec 20, 2027High confidence
8 of 8 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited